The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vermilion Energy Inc
NYSE:VET
|
CA |
|
Decibel Cannabis Company Inc
OTC:DBCCD
|
CA |
|
Dayu Water-saving Group Co Ltd
SZSE:300021
|
CN |
|
Truist Financial Corp
NYSE:TFC
|
US |
|
G
|
Genpact Ltd
SWB:35G
|
BM |
|
U
|
US Bancorp
XHAM:UB5
|
US |
|
S
|
Safran SA
DUS:SEJ1
|
FR |
|
S&P Global Inc
NYSE:SPGI
|
US |
|
Man Wah Holdings Ltd
F:AAM
|
HK |
|
S
|
Sumitomo Mitsui Financial Group, Inc
F:XMF
|
JP |
|
I
|
Insperity Inc
F:ASF
|
US |
|
E
|
Enbridge Inc
DUS:EN3
|
CA |
|
Cheil Grinding Wheel Ind Co Ltd
KRX:001560
|
KR |
|
V
|
Vale SA
SWB:CVLC
|
BR |
|
Vonovia SE
XETRA:VNA
|
DE |
|
Stratasys Ltd
NASDAQ:SSYS
|
US |
|
C
|
Coats Group PLC
F:4TC
|
UK |
|
I
|
Iovance Biotherapeutics Inc
SWB:2LB
|
US |
|
A
|
Alba Mineral Resources PLC
OTC:ALBAF
|
UK |
|
Inspire Medical Systems Inc
NYSE:INSP
|
US |
|
Bluestone Jewellery and Lifestyle Ltd
NSE:BLUESTONE
|
IN |
|
Kudelski SA
OTC:KDCXF
|
CH |
|
China Oilfield Services Ltd
SSE:601808
|
CN |
|
Metro Performance Glass Ltd
NZX:MPG
|
NZ |
Vermilion Energy Inc (VET)’s 12-month stock price forecast through November 2027 has a consensus target of $16.06, implying 53% upside. The forecast is based on price targets from 11 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
VET is 16.06 USD with a low forecast of 12.29 USD and a high forecast of 21.04 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 4 years is 8%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next -6 years is -1%.
Over the last 13 years, the compound annual growth rate for Operating Income has been -7%. The projected CAGR for the next 5 years is 33%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more